Survivorship and Quality of Life in Head and Neck Cancer.

Head and neck cancer is becoming more common, and survival rates are improving. Human papillomavirus-associated oropharyngeal cancer, in particular, is increasing in incidence and is associated with an excellent prognosis. However, toxicity from disease and treatment leads to long-term impairment, disability, and handicap. Currently, more than 60% of survivors have unmet needs. As the numbers of survivors increase, current models of care will be increasingly inadequate to meet their needs. Exploration of new strategies and models of care to better address quality-of-life issues and meet the needs of survivors of head and neck cancer is urgently required.

[1]  M. King,et al.  Integrating health-related quality of life findings from randomized clinical trials into practice: an international study of oncologists’ perspectives , 2015, Quality of Life Research.

[2]  D. Cella,et al.  Outcomes toolbox for head and neck cancer research , 2015, Head & neck.

[3]  Kevin C Oeffinger,et al.  Causes of death in long‐term survivors of head and neck cancer , 2014, Cancer.

[4]  J. Ringash Facing head and neck cancer deaths head on: Lessons for survival , 2014, Cancer.

[5]  J. Ringash,et al.  Health related quality of life in head and neck cancer treated with radiation therapy with or without chemotherapy: a systematic review. , 2013, Oral oncology.

[6]  D. Brachman,et al.  The impact of concurrent granulocyte–macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial , 2014, Quality of Life Research.

[7]  I. Barillot,et al.  An international phase 3 trial in head and neck cancer: Quality of life and symptom results , 2014, Cancer.

[8]  Jacques Ferlay,et al.  Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  G. Hordijk,et al.  Long-term effect of a nurse-led psychosocial intervention on health-related quality of life in patients with head and neck cancer: a randomised controlled trial , 2013, British Journal of Cancer.

[10]  C. Ferreira,et al.  Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  M. Hier,et al.  Head and neck cancer patients want us to support them psychologically in the posttreatment period: Survey results , 2013, Palliative and Supportive Care.

[12]  K. Courneya,et al.  Pilot, randomized trial of resistance exercise during radiation therapy for head and neck cancer , 2013, Head & neck.

[13]  P. Aagaard,et al.  Progressive resistance training rebuilds lean body mass in head and neck cancer patients after radiotherapy--results from the randomized DAHANCA 25B trial. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  T. Gupta,et al.  Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study. , 2013, Oral oncology.

[15]  M. Vidyasagar,et al.  Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy—a randomized controlled trial , 2013, Supportive Care in Cancer.

[16]  M. Vidyasagar,et al.  Effect of exercise training on functional capacity & quality of life in head & neck cancer patients receiving chemoradiotherapy , 2013, The Indian journal of medical research.

[17]  S. Ristovski-Slijepcevic,et al.  Cancer survivorship: why labels matter. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  D. Moher,et al.  Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards , 2012, Quality of Life Research.

[19]  D. Rietveld,et al.  Five‐year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra‐arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer , 2012, Head & neck.

[20]  C. Leles,et al.  Effect of intraoral low‐level laser therapy on quality of life of patients with head and neck cancer undergoing radiotherapy , 2012, Head & neck.

[21]  L. Johansson,et al.  Impact of prophylactic percutaneous endoscopic gastrostomy on malnutrition and quality of life in patients with head and neck cancer — a randomized study , 2012, Head & neck.

[22]  A. Bezjak,et al.  Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers , 2011, Quality of Life Research.

[23]  Eric J Feuer,et al.  Projections of the cost of cancer care in the United States: 2010-2020. , 2011, Journal of the National Cancer Institute.

[24]  A. Bottomley,et al.  Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323) , 2010, British Journal of Cancer.

[25]  H. Brenner,et al.  Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. , 2010, The oncologist.

[26]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[27]  J. Dunn,et al.  Predictors of change in unmet supportive care needs in cancer , 2010, Psycho-oncology.

[28]  N. Scott,et al.  EORTC Quality of Life Group translation procedure , 2009 .

[29]  R. Martino,et al.  Evaluation of quality of life and organ function in head and neck squamous cell carcinoma. , 2008, Hematology/oncology clinics of North America.

[30]  A. Garden,et al.  Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis. , 2008, International journal of radiation oncology, biology, physics.

[31]  A. Chaturvedi,et al.  Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  Gordon H Guyatt,et al.  Exploration of the value of health-related quality-of-life information from clinical research and into clinical practice. , 2007, Mayo Clinic proceedings.

[33]  D. Redelmeier,et al.  Interpreting clinically significant changes in patient‐reported outcomes , 2007, Cancer.

[34]  A. Garden,et al.  TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. , 2007, The Lancet. Oncology.

[35]  K. Ang,et al.  Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  David J Weiss,et al.  Psychometric Evaluation and Calibration of Health-Related Quality of Life Item Banks: Plans for the Patient-Reported Outcomes Measurement Information System (PROMIS) , 2007, Medical care.

[37]  D. Goldstein,et al.  Health‐related quality of life profiles based on survivorship status for head and neck cancer patients , 2007, Head & neck.

[38]  J. Sham,et al.  Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. , 2006, International journal of radiation oncology, biology, physics.

[39]  A. Garden,et al.  Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  A. Bezjak,et al.  Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: A report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis , 2005, Head & neck.

[41]  G. Lockwood,et al.  Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. , 2005, International journal of radiation oncology, biology, physics.

[42]  R. Greil,et al.  Normative data for functional assessment of cancer therapy General scale and its use for the interpretation of quality of life scores in cancer survivors , 2004, Acta oncologica.

[43]  S. Straus,et al.  Learning in practice The case for knowledge translation : shortening the journey from evidence to effect , 2003 .

[44]  Robert L. White,et al.  Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer--RTOG 97-09. , 2003, International journal of radiation oncology, biology, physics.

[45]  G. Norman,et al.  Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.

[46]  S. Fosså,et al.  Quality of life during radiotherapy for rectal cancer. , 2003, European journal of cancer.

[47]  D. Patrick,et al.  Assessing meaningful change in quality of life over time: a users' guide for clinicians. , 2002, Mayo Clinic proceedings.

[48]  R. Biggar,et al.  Changing patterns of tonsillar squamous cell carcinoma in the United States , 2000, Cancer Causes & Control.

[49]  M. Sprangers,et al.  Integrating response shift into health-related quality of life research: a theoretical model. , 1999, Social science & medicine.

[50]  D. Osoba,et al.  Completion rates in health-related quality-of-life assessment: approach of the National Cancer Institute of Canada Clinical Trials Group. , 1998, Statistics in medicine.

[51]  G H Guyatt,et al.  Users' guides to the medical literature. XII. How to use articles about health-related quality of life. Evidence-Based Medicine Working Group. , 1997, JAMA.

[52]  J. Wright,et al.  The minimal important difference: who's to say what is important? , 1996, Journal of clinical epidemiology.

[53]  S. Franceschi,et al.  Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[54]  D L Sackett,et al.  An assessment of clinically useful measures of the consequences of treatment. , 1988, The New England journal of medicine.

[55]  D. Karnofsky,et al.  The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma , 1948 .

[56]  Patricia A. Ganz,et al.  From cancer patient to cancer survivor : lost in transition , 2006 .

[57]  D. Osoba,et al.  Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group. , 2005, European journal of cancer.

[58]  A. Bezjak,et al.  Oncologists' use of quality of life information: Results of a survey of Eastern Cooperative Oncology Group physicians , 2004, Quality of Life Research.

[59]  P. Schoemaker The Expected Utility Model: Its Variants, Purposes, Evidence and Limitations , 1982 .